SCHEMBL3164656

SCHEMBL3164656

CCOC(=O)C1CCN(C(=O)C(=O)Nc2cc(NCCNC(C)=O)nc(-c3ccccc3)n2)CC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ KDM4E B2RXH2 7/20 0.45
▸ P2RY12 Q9H244 2/20 0.44
▸ PTGS1 P23219 1/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ PTGS2 P35354 1/20 0.43
▸ AURKA O14965 1/20 0.42
▸ AURKB Q96GD4 1/20 0.42
▸ MAPT P10636 3/20 0.42
▸ TSHR P16473 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ HPGD P15428 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ CASP1 P29466 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3170981 0.90 HTT (0.49) MEN1KMT2ASMN1; SMN2KDM4EP2RY12
SCHEMBL3165495 0.88 TDP1 (0.45) SMN1; SMN2KDM4ETSHRTP53ALDH1A1
SCHEMBL3169774 0.87 ADORA2A (0.43) KDM4EP2RY12MAPTTSHRTP53
SCHEMBL3163481 0.85 ADORA2A (0.41) P2RY12TSHRTP53ALDH1A1HSD17B10
SCHEMBL3162937 0.85 ADORA2A (0.46) KDM4EP2RY12MAPTTSHRTP53
SCHEMBL3174594 0.84 ADORA2A (0.45) KDM4EP2RY12MAPTTSHRTP53
SCHEMBL3175769 0.84 ADORA2A (0.45) KDM4EP2RY12MAPTTSHRTP53
SCHEMBL3166225 0.84 ADORA2A (0.45) KDM4EP2RY12MAPTTSHRTP53
SCHEMBL3172373 0.84 GRIN2D (0.49) MEN1KMT2AMAPTNPSR1
SCHEMBL3162870 0.84 NPSR1 (0.44) MEN1KMT2AKDM4EP2RY12NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback